
Transactions: Healthcare
Filter


Private placement of equity in M&E Biotech A/S (DK) — DKK 32 million

Rights issue in Karo Bio (SE) — SEK 125 million

Divestment of Swedish Orphan International AB (SE) to Investor Growth Capital (SE) and Skandia Investment (SE) — Amount not disclosed.

Secondary placing of 3 million shares in Meda (SE) — SEK 720 million

Rights offering in Medivir (SE) — SEK 325 million

Rights issue in Oasmia Pharmaceutical (SE) — SEK 123 million

Directed issue of shares in Active Biotech (SE) — SEK 340 million

Acquisition and new share issue in Elekta AB (SE) — Amount not disclosed.

Private placement of equity in BioInvent International AB (SE) — SEK 194 million

Option program in Biacore (SE)
